Qingkai Wang1, Na Wang, Xin Zhang, Weiguo Hu. 1. Fudan University Shanghai Cancer Center and Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, P.R.China.
Abstract
The fifth component of complement (C5) is considered to be the center of complement activation and function. However, there are no genetically engineered knockout mice for this gene, and the only commercially available inherited C5-deficient mice, in which a "TA" nucleotide deletion in the coding frame was previously identified, are in theC57BL/10Sn genetic background rather than the commonly used backgrounds C57BL/6 and BALB/c. Therefore, these mice must be backcrossed into the desired genetic background. Here, we developed an ARMS (amplification refractory mutation system) PCR method using a specific primer pair that was able to discriminate between the genotypes when the resulting product was analyzed by agarose gel electrophoresis. These results were supported by quantitative RT-PCR and semi-quantitative PCR and were consistent with the results from sequencing each backcrossed generation. Using ARMS-PCR method, we generated C5-deficient mice in the C57BL/6 background over 9 backcrossed generations and further verified the phenotype using complement-mediated hemolytic assays. In this study, we describe a simple, rapid and reliable PCR-based method for genotyping inherited C5-deficient mice that may be used to backcross C57BL/10Sn mice into other genetic backgrounds.
The fifth component of complement (C5) is considered to be the center of complement activation and function. However, there are no genetically engineered knockout mice for this gene, and the only commercially available inherited C5-deficientmice, in which a "TA" nucleotide deletion in the coding frame was previously identified, are in theC57BL/10Sn genetic background rather than the commonly used backgrounds C57BL/6 and BALB/c. Therefore, these mice must be backcrossed into the desired genetic background. Here, we developed an ARMS (amplification refractory mutation system) PCR method using a specific primer pair that was able to discriminate between the genotypes when the resulting product was analyzed by agarose gel electrophoresis. These results were supported by quantitative RT-PCR and semi-quantitative PCR and were consistent with the results from sequencing each backcrossed generation. Using ARMS-PCR method, we generated C5-deficientmice in the C57BL/6 background over 9 backcrossed generations and further verified the phenotype using complement-mediated hemolytic assays. In this study, we describe a simple, rapid and reliable PCR-based method for genotyping inherited C5-deficientmice that may be used to backcross C57BL/10Sn mice into other genetic backgrounds.
The complement system can be activated via the classical, alternative and lectin pathways,
and the cleaved complement fragments and complexes execute versatile functions, including
efficient immune surveillance and modulation of immunological and inflammatory processes.
Upon activation, complement cascades converge at the C3 level using distinct C3 convertases
that subsequently trigger the formation of fifth complement component (C5) convertases, thus
leading to the cleavage of C5 to C5b and anaphylatoxin C5a. The C5b-7 complex inserts into
the targeted cell membrane and assembles with C8 and C9, thereby inducing the polymerization
of C9 to form a lytic pore, termed the membrane attack complex (MAC) [20]. C5a, the most potent anaphylatoxin, is a major pro-inflammatory
mediator that involves in a wide range of diseases because it not only regulates the
inflammatory process in innate immunity but also comprehensively modulates the adaptive
immune response [9]. C5 can be cleaved independently
of C3 convertase by serine proteases such as thrombin [6]. Therefore, C5 is considered to be at the center of complement activation and
function.A mouse with sufficient or deficient expression of a certain gene is a powerful tool to
investigate the function of the gene. A genetic congenic strain usually refers to specially
inbred strains of mice that differ only in restricted regions of the genome, and can be
produced by repeated backcrosses to an inbred (background) strain with selection for a
particular marker from the donor strain. C57BL/6 mice are the most widely used inbred strain
of laboratory mice that can be genetically modified to serve as human disease models due to
the availability of congenic strains, its easy breeding and robustness, clear genetic
background and entire genome sequence. BALB/c mice are also inbred mice that are widely used
in experimental research on immunology and cancer. This strain of mice is particularly well
known for the production of monoclonal antibodies. Other stains, such as C3H/He, DBA/1 and
129/Sv, are also commonly used for different research purposes. However, the available
C5-deficientmouse strains in The Jackson Laboratory are the C57BL/10Sn, DBA/2J, A/HeJ,
AKR/J, NZB/BINJ, and SWR/J rather than C57BL/6J background.This line was developed by Dr. George Snell during the late 1940s and early 1950s using
tumor rejection to select each generation from an initial cross between C57BL/10Sn and DBA/2
mice. The DBA/2J strain, together with five other strains (A/HeJ, AKR/J, NZB/BlNJ, SWR/J and
B10.D2/oSnJ), was later found to be inherited C5-deficient
(Hc, homozygous mutations at the
Hc gene locus on chromosome 2) due to a 2-base pair “TA” deletion at
positions 661 and 662 of the C5 mRNA (NM_010406.2) coding frame [28]. The consequence of this deletion is the creation of a stop codon at
positions 707–709 rather than at normal positions 5099–5101 in the mRNA, thus resulting in
C5 deficiency. Until now, no one, including the strain provider, has developed a typical
genotyping protocol for these mice. Although a recently reported gene-sequencing method
provides an alternative approach to C5-deficient genotyping, it appears to be complicated
[2]. Backcrossing into the desired genetic
background for 9 generations is ideal to refine a lineage, and the method described here
provides a simple and rapid approach for genotyping the inherited C5-deficient sequence.Amplification refractory mutation system (ARMS)-PCR can rapidly analyze a known mutation in
genomic DNA and provide an easy way to visually inspect a PCR amplification product in an
agarose gel [15]. In this study, we designed a pair
of specific primers to amplify the unmutated DNA chain in
Hc and
Hc mice using ARMS-PCR. This method resulted
in a stronger band for Hc than for
Hc mice on an agarose gel, and no product
was amplified for Hc mice. Thus, the strong,
weak and absent bands in the agarose gel represent the
Hc,
Hc and
Hc genotypes, respectively. This method was
further verified by sequencing and by functional tests. Therefore, we provide a simple,
rapid and reliable method of genotyping inherited C5-deficientmice.
Material and Methods
Animals and breeding
Parental wild-type C57BL/6 (Stock Number SLAC-0307, SLAC Laboratory Animal Co., Ltd.,
Shanghai, P.R. China) and C5-deficient (Stock Number 000461, background strain C57BL/10Sn,
The Jackson Laboratory, Bar Harbor, Maine) mice were maintained at the animal facility of
the Shanghai Medical School, Fudan University. All rodent work was performed with the
consent of the Animal Ethics Committee at Shanghai Medical School, Fudan University. All
the animals were fed a standard diet and maintained in a pathogen-free environment on a
12-h light/12-h dark cycle with ad libitum access to rodent chow.Each breeding cage contained 1 male and 3 females that were approximately 8 weeks of age.
The first generation of heterozygous Hc mice
was obtained by crossing C57BL/6 and C5-deficient C57BL/10Sn mice. Then, the resulting
Hc mice, termed the first generation, were
backcrossed with C57BL/6 for 9 generations. Finally,
Hc mice were intercrossed to obtain
homozygous Hc mice with a pure C57BL/6 genetic
background. At each generation, we checked at least ten offspring to determine the
genotype using both gene sequencing and ARMS-PCR methods.
DNA extraction from the mouse tail
At least 3 mm of the mouse tail was cut, and the bleeding was immediately stanched using
mono-polar electrocoagulation. Genomic DNA was then extracted using the TailGen DNA Kit
(CoWin Bioscience, Beijing, China), quantified using a NanoVueTM
spectrophotometer (GE Healthcare Life Sciences, Pittsburgh, PA) and stored at −20°C until
use as a PCR template.
Gene sequencing
We used a common reverse primer (R) and designed a forward primer1 (F1), as shown in
Fig. 1, to amplify the genomic fragments by PCR. The resulting fragment was 179 bp or 177
bp in length, depending on if the “TA” mutation site was present or deleted. Each PCR
reaction was performed as follows: denaturation at 95°C for 3
min; then denaturation at 95°C for 15 s, annealing at 56°C for 25 s and
extending at 72°C for 20 s for 30 cycles; followed by a final extension at
72°C for 1 min. The 20-µl reaction mixtures contained
2 µl of 5× buffer, 1.6 µl of 2.5 µM
dNTP, 0.5 µl of 10 µM primers, 200 ng of template and
0.2 µl of rTaq Takara TaqTM (Takara Biotechnology, Dalian,
China). The reaction was brought up to 20 µl with double-distilled
H2O (ddH2O).
Fig. 1.
The corresponding C5 gene sequences and primer design. The C5 gene sequences inside
the rectangle from bp 18213 to 18391 contain the “TA” deletion (underlined and
italic) in the inherited C5-deficient mice. F1 and the R were used in the PCR to
amplify DNA for gene sequencing and ARMS-PCR, while forward primer 2 (F2) combined
with R were used in the ARMS-PCR and qRT-PCR assays. β-actin forward primer and
β-actin reverse primer was untilized in semi-qPCR as internal control corresponding
to F2/R with Hc and
Hc mice template.
The corresponding C5 gene sequences and primer design. The C5 gene sequences inside
the rectangle from bp 18213 to 18391 contain the “TA” deletion (underlined and
italic) in the inherited C5-deficientmice. F1 and the R were used in the PCR to
amplify DNA for gene sequencing and ARMS-PCR, while forward primer 2 (F2) combined
with R were used in the ARMS-PCR and qRT-PCR assays. β-actin forward primer and
β-actin reverse primer was untilized in semi-qPCR as internal control corresponding
to F2/R with Hc and
Hc mice template.The PCR products were purified for gene sequencing by Biosune Biotechnology Co.
(Shanghai, China), and the results were compared with the C5 genomic sequence of the
C57BL/6J background that is available in the National Center for Biotechnology Information
database (NC_000068.7, 34983331..35061449, chromosome 2, Mus musculus
strain C57BL/6J).To further confirm the genetic background of the harvested C5-deficient C57BL/6 mice, we
also cut mouse tails from 2 females and 2 males C5-deficientmice (F9 in
C57BL/6 background), 2 females and 2 males C5-deficientmice (F0 in C57BL/10Sn
background) and 1 male wild type C57BL/6 mouse (positive control). The mouse
tail DNA was isolated as describe above and sent for marker loci examination on each
chromosome in a third-party company, Shanghai Biowing Applied Biotechnology Co., Ltd.
(Wuxi, Jiangsu, China).
ARMS-PCR and Semi-quantitative PCR
Based on the mechanism of the ARMS-PCR, we designed forward primer 2 (F2) to amplify
genomic fragments containing the mutated sequence when paired with the reverse primer
(Fig. 1). Each PCR reaction was performed
sequentially as follows: 95°C for 3 min followed by 35 cycles of 15 s at 95°C, 25 s at
62°C and 20 s at 72°C in the same reaction solution as mentioned
above. And semi-qPCR was also performed to further validate the results of ARMS-PCR using
a 360 bp β-actin genomic DNA fragment as internal control under the same
condition but corresponding primer (Fig. 1). Ten
microliters of each PCR product was electrophoresed through a 2% (wt/v) agarose gel that
was then stained with ethidium bromide and photographed.Considering that the quality and amount of DNA template may affect the amplification
efficacy of ARMS-PCR and further assessment of the result, we performed DNA quality
control by measuring OD260/OD280 ratio. Meanwhile, we optimized the amount of DNA template
as indicated in Fig. 3E in ARMS-PCR with F2/R primers.
Fig. 3.
ARMS-PCR, semi-qPCR and qRT-PCR with F1/R and/or F2/R in C5-deficient,
C5-sufficient and heterozygous mice. (A) Comparison of the ARMS-PCR products using
Hc or
Hcmouse DNA as template with F2/R;
(B) comparison of ARMS-PCR products using
Hc and
Hcmouse DNA as template; (C)
Comparison of semi-qPCR products using
Hc and
Hcmouse DNA (200 ng) as template
only via F2/R corresponding to respective β-actin control; M: DNA marker. (D) The
qRT-PCR curves with F2/R primers and 200 ng different templates. (E) Comparison of
ARMS-PCR products using different amount of
Hc and
Hcmouse DNA as templates with F2/R
primers.
ARMS-PCR, semi-qPCR and qRT-PCR with F1/R and/or F2/R in C5-deficient,
C5-sufficient and heterozygous mice. (A) Comparison of the ARMS-PCR products using
Hc or
Hcmouse DNA as template with F2/R;
(B) comparison of ARMS-PCR products using
Hc and
Hcmouse DNA as template; (C)
Comparison of semi-qPCR products using
Hc and
Hcmouse DNA (200 ng) as template
only via F2/R corresponding to respective β-actin control; M: DNA marker. (D) The
qRT-PCR curves with F2/R primers and 200 ng different templates. (E) Comparison of
ARMS-PCR products using different amount of
Hc and
Hcmouse DNA as templates with F2/R
primers.
Quantitative real time PCR (qRT-PCR)
DNA extracts from Hc1/Hc1, Hc1/Hc0 and Hc0/Hc0 mice were used as templates, and forward
primer 2 and the reverse primer served as the primer pair. qRT-PCR was performed in a
total volume of 10 µl according to the manufacturer’s guidelines (Cat
No.: 4367695, Invitrogen Co., Ltd.). The reaction program was set as follows: 10 min at
95°C followed by 45 cycles of 15 s at 95°C, 25 s at 62°C and 20 s at 72°C using an ABI
7900HT Fast Real-Time PCR System (Cat No.:7900HT, Applied Biosystems, Thermo Fisher
Scientific Inc.). Each reaction included 3 replicates and a negative control with
ddH2O in place of template.
Complement-mediated hemolysis
Human erythrocytes were collected from one healthy individual and stored in Alsever’s
solution (Sigma-Aldrich, St. Louis, MO) at 4°C until use within three days. Mouse blood
samples were obtained from the inferior vena cava of C57BL/10Sn and C57BL/6 C5-deficient,
and C57BL/6 wild-type mice (3 mice in each group) after anesthetization with diethyl
ether. After clotting for 45 min at room temperature, serum was
harvested by centrifugation at 10,000 rpm for 10 min at 4°C, then pooled and used
immediately. Then, hemolytic assays were performed to test complement function, as
described previously [5].
Statistical analysis
The results of hemolysis were analyzed with two way ANOVA analysis by statistical
software GraphPad Prism 5.0.
Results
Identification of the C5-deficient mouse genotype using gene sequencing
Based on the complement C5 gene sequence, we designed forward primer 1 and a reverse
primer, as shown in Fig. 1, to amplify the
“TA”-containing DNA fragment by PCR. The expected PCR product sizes were179 bp for
Hc mice and 177 bp for
Hc mice due to the “TA” nucleotide
deletion, while heterozygous Hc mice were
expected to form both PCR products. It was difficult to discriminate between these two
bands via agarose gel electrophoresis. Therefore, the fragments were purified and
sequenced. The results clearly showed that the “TA” nucleotides were deleted in
C5-deficient C57BL/10Sn mice (Fig. 2A) but were
retained in C5-sufficient C57BL/6 mice (Fig.
2B). However, double-colored peaks appeared from the deleted “TA” position in the
sequencing chromatograms of heterozygous mice resulting from crossing C57BL/10Sn with
C57BL/6 mice (Fig. 2C) due to the presence of
two different chromosomes either with or without this deletion. During the entire process
of backcrossing heterozygous mice to the C57BL/6 background, we repeated the same
procedure to verify the mouse genotype. The data demonstrated that all the offspring in
each generation were Hc or
Hc mice for nine generations (data not
shown).
Fig. 2.
Gene sequencing of the PCR products amplified withforward primer 1 and the reverse
primer. (A) C5-deficient mice in the C57BL/10Sn background; (B) C5-sufficient mcie
in the C57BL/6 background; (C) heterozygous mice in the C57BL/6 and C57BL/10Sn
backgrounds; (D) C5-deficient mice in the C57BL/6 background; and (E) C5-sufficient
mice in the BALB/c background. The deleted and retained “TA” nucleotides are
highlighted inside the rectangle, and the sequences were obtained with reverse
primer.
Gene sequencing of the PCR products amplified withforward primer 1 and the reverse
primer. (A) C5-deficientmice in the C57BL/10Sn background; (B) C5-sufficient mcie
in the C57BL/6 background; (C) heterozygous mice in the C57BL/6 and C57BL/10Sn
backgrounds; (D) C5-deficientmice in the C57BL/6 background; and (E) C5-sufficient
mice in the BALB/c background. The deleted and retained “TA” nucleotides are
highlighted inside the rectangle, and the sequences were obtained with reverse
primer.
Identification of the C5-deficient mouse genotype using ARMS-PCR
Although gene sequencing was able to identify the mouse genotype, this method was
complicated and time-consuming. PCR is a widely used method for genotyping genetically
engineered mice. Based on the deletion mutation in C5-deficientmice, we employed ARMS-PCR
to identify this deletion using the specific forward primer 1, forward primer 2 and a
reverse primer (Fig.
1). Forward primer 2 contains a 3-bp mutation at its 3′ terminus,
i.e., one “A/T” mutation and two “AT” deletion mutations, which made it impossible to
amplify the gene from C5-deficientmice at a given annealing temperature. The ARMS-PCR
resulted in a clear band in the agarose gel when using DNA extracted from C5-sufficient
C57BL/6 mice, but no band was evident when using template from C5-deficient C57BL/10Sn
mice (Fig. 3A).At each generation resulting from backcrossing the
Hc mice to the
Hc C57BL/6 background, the offspring
demonstrated both the Hc and
Hc genotypes. The ARMS-PCR products of
Hc mice with F2/R primer pair may
theoretically show a band of approximately half the intensity of that of the
Hc mice with F1/R primer pair because only
the single chromosome that lacks the mutation is an effective template in the PCR
reaction. Indeed, the products amplified from DNA extracted from the
Hc mice with F2/R primer pair were less
bright than those from Hc mice with primer
F1/R primer pair in an agarose gel (Fig. 3B).
While using F1/R and F2/R primer pair respectively, the products of
Hc mice were nearly identical resulting to
the twins-like brightness. These results were further supported by semi-quantitative PCR
and quantitative RT-PCR assays, in which products of β-actin control of
Hc mice and
Hc mice with its primer pair seemed to be
the same, but there was a distinct consequence for F2/R primer pair with the same template
(Fig. 3C). On the other hand, the delta
normalized reporter (∆Rn) represents the magnitude of the signal generated by a given set
of PCR conditions. As shown in Fig. 3D, the
values of the ∆Rn for Hc mice were 1.7-
(4116/2433) and 4.5-fold (2623/583) higher than those for
Hc mice at 45 and 35 cycles, respectively.
However, the ∆Rn value for Hc mice was
approximately zero due to the lack of an effective template. Critically, all the results
from the ARMS-PCR were consistent with those from gene sequencing at each generation of at
least ten offspring, demonstrating the accuracy of ARMS-PCR in genotyping the inherited
C5-deficency. Therefore, this simple and rapid ARMS-PCR assay provides an alternative
approach to the complicated gene sequencing method for genotyping inherited C5-deficientmice.It should be noted that the principal of the current ARMS-PCR method for discriminating
Hc mutant genotype depends on accuracy of band intensity. Only in
heterozygous mice, the ARMS-PCR product bands with F2/R primers display half intensity of
those with F1/R primers (Fig. 3B). Therefore, we
recommend: 1) the ARMS-PCR with tetra-primer (F1/R and F2/R) appears better than with only
one pair of primer (F/R), in which the F1/R primers can be at least regarded as the
positive control; 2) the quality of DNA template is essential. The reliable commercial
mouse tail DNA isolation kit and the subsequent OD260/OD280 ratio
measurement are required. In this study the OD260/OD280 ratio of
mouse tail DNA samples is 1.8 to 2.0 (data not shown); and 3) the template DNA amounts
need to be optimized. The extremely-low or –high concentrated DNA templates may make a
difficult even incorrect assessment. As shown in Fig.
3E, we chose 200 ng DNA templates for the experiments, the PCR band produced by
which seems appropriate.
Verification of the C5 deficiency in the C57BL/6 background
After 9 generations of backcrossing C57BL/10Sn to C57BL/6 mice, we obtained C5-deficientmice in the C57BL/6 background. In each generation, we determinedthe mouse genotype via
ARMS-PCR and further verified the genotype by gene sequencing (Fig. 2D). Moreover, the C5-deficientmice were functionally
verified by complement-mediated hemolysis assays. Human erythrocytes were sensitized by
rabbit anti-human erythrocyte polyclonal antibodies and then incubated with different
concentrations of mouse serum from wild-type or C5-deficient C57BL/6 mice. As shown in
Fig. 4, wild-type mouse serum induced remarkable hemolyis in a
dose-dependent manner. In contrast, C5-deficient C57BL/6J and C57BL/10Sn mouse sera
produced negligible hemolysis due to the lack of C5 and, more importantly there are no
difference of hemolytic activity between C57BL/6J and C57BL/10Sn mouse serum. Furthermore,
we examined the marker loci on each chromosome of four C5-deficient and one wild type
mouse with C57BL/6 genetic background in compared with database of wild type C57BL/6J, and
found that all the marker loci are exactly same among them in all 20 chromosomes (data not
shown). In addition, considering that tiny amounts of locus in C57BL/10Sn might be
retained to C57BL/6J in Hc mice, we randomly
selected three SNPs (rs13477866, rs13476874 and rs6271003) between C57BL/6J and C57BL/10Sn
to exclude this possibility. The results also revealed that three tested SNPs in four
Hc C57BL/6J mice are same as those in
wildtype C57BL/6J mice, which are truly different from those in
Hc and wildtype C57BL/10Sn mice.
Therefore, we sucessfully established a simple and rapid method for genotyping inherited
C5-deficientmice and generated C5-deficientmice in the C57BL/6 background.
Fig. 4.
The complement-mediated hemolytic assay. Complement was activated by anti-human
erythrocyte polyclonal antibodies, and mouse serum from wild-type or C5-deficient
mice of the C57BL/6 background was usedas a source of complement. The data
represent the mean ± sd, n=3 and were analyzed with GraphPad Prism software. **
P<0.01 and * P<0.05 vs. WT.
The complement-mediated hemolytic assay. Complement was activated by anti-human
erythrocyte polyclonal antibodies, and mouse serum from wild-type or C5-deficientmice of the C57BL/6 background was usedas a source of complement. The data
represent the mean ± sd, n=3 and were analyzed with GraphPad Prism software. **
P<0.01 and * P<0.05 vs. WT.
Discussion
C5 is a critical component in complement cascade, and the accumulating evidence implied
that C5 plays a critical role in whole process of many inflammatory diseases and some kinds
of tumors [7, 8,
10, 11,
13, 14,
18, 20].
Therefore, inhibition of C5a-C5aR axis has been demonstrated an effective therapeutic
approach for some human diseases with uncontrolled and deleterious complement activation
[1, 13, 27, 30]. The
inherited C5-deficienthuman being families [4, 12, 22, 23, 25] and more
importantly mouse strains [3, 16, 17, 19, 21, 24, 26, 27, 29] have already been
reported, which triggers the field to produce a C5-deficientmouse strain for experiment
study. Although Wetsel et al. revealed that a 2-base pair gene deletion
resulted in the inherited C5 deficiency in some mouse stains including DBA/2J background
[28], there is no available C5-deficient stains in
the common genetic backgrounds such as C57BL/6J. Therefore, in this study we generated a
simple ARMS-PCR-based method for rapidly genotyping the inherited C5-deficientmice in
backcrossed C57BL/6 background. Meanwhile, using this method we successfully produced the
inherited C5-deficientmice with pure C57BL/6 background by nine-generation backcross, which
were further proved by gene sequencing, functional test and marker loci examination on each
chromosome.In our ARMS-PCR method, design of the specific second pair of primers F2/R is the most
critical, in which F2 forward primer can induce three nucleotides mismatch in 3′ terminal
only happening in the Hc mutant chromosome. Therefore,
Hc mouse DNA templates with two effective
chromosomes could produce about 2-fold stronger bands than
Hc mouse with only one effective chromosome;
while there was no visible band for Hc mouse due
to without any effective template. Given the limited number of amplification cycles for a
certain amount of DNA template in ARMS-PCR method, the quality and amount of DNA templates
should be the crucial determinant. Here, to successfully generate the ARMS-PCR method, we
first controlled the quality of DNA templates by using a reliable mouse DNA isolation kit
and further measuring the ratio of OD260/OD280. Next we still
optimized the amount of templates as 200 ng with 35 amplification cycles in ARMS-PCR (Fig. 3E). Therefore, we strongly believe that the
quality control and amount optimization of DNA templates are prerequisites for the
successful of ARMS-PCR method. Together with the results of hemolytic assay, gene sequencing
and marker loci examination on each chromosome, the ARMS-PCR results strongly demonstrated
that the harvested mutant mice with nine-generation backcross are indeed inherited
C5-deficient in C57BL/6 genetic background.Therefore, ARMS-PCR is a simple, rapid and reliable method for mouse genotyping. It can
also be used in the generation of inherited C5-deficientmice in another genetic background
such as BALB/c. According to the sequence of the gene in the BALB/c strain, the same
ARMS-PCR primers can be used without any changes (Fig.
2E). Furthermore, this method can be used to genotype other mouse strains with
different inherited gene deletions.
Disclosures
The authors declare no competing financial interests.
Authors: C R Newton; A Graham; L E Heptinstall; S J Powell; C Summers; N Kalsheker; J C Smith; A F Markham Journal: Nucleic Acids Res Date: 1989-04-11 Impact factor: 16.971